BioNexus Gene Lab (BGLC) Stock Price
BioNexus Gene Lab Price
Revenue has compounded at 69.8% per year over the past 8 years to 7.42 M USD. Earnings per share have declined at 55.6% per year over the last 3 years. BioNexus Gene Lab's net margin stands at -40.2%, down from 5.6% several years earlier.
BioNexus Gene Lab stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
BioNexus Gene Lab business model & stock analysis
Frequently asked questions about BioNexus Gene Lab
Converted at the current exchange rate, the BioNexus Gene Lab share trades at 0.97 EUR (1.08 USD).
The BioNexus Gene Lab share (BGLC) is listed on 3 stock exchanges, including: NASDAQ (BGLC).
The revenue cannot currently be calculated for BioNexus Gene Lab.
The profit cannot currently be calculated for BioNexus Gene Lab.
The P/E ratio cannot be calculated for BioNexus Gene Lab at the moment.
The P/S cannot be calculated for BioNexus Gene Lab currently.
The Eulerpool Quality Score for BioNexus Gene Lab is 1/10.
The ISIN of BioNexus Gene Lab is US0906283066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of BioNexus Gene Lab is BGLC. The ticker symbol is used to trade BioNexus Gene Lab shares on the stock exchange.
BioNexus Gene Lab stock
BioNexus Gene Lab Peer Group
BioNexus Gene Lab Ticker
All fundamentals and in-depth analysis of BioNexus Gene Lab
Our stock analysis for BioNexus Gene Lab stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioNexus Gene Lab. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.